Yao Lu

740 total citations · 1 hit paper
47 papers, 372 citations indexed

About

Yao Lu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yao Lu has authored 47 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 33 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Yao Lu's work include Hepatitis B Virus Studies (33 papers), Hepatitis C virus research (30 papers) and Liver Disease Diagnosis and Treatment (27 papers). Yao Lu is often cited by papers focused on Hepatitis B Virus Studies (33 papers), Hepatitis C virus research (30 papers) and Liver Disease Diagnosis and Treatment (27 papers). Yao Lu collaborates with scholars based in China, United States and Australia. Yao Lu's co-authors include Lu Zhang, Minghui Li, Ge Shen, Min Chang, Leiping Hu, Yao Xie, Wei Yi, Hongxiao Hao, Shuling Wu and Gang Wan and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Microbiology and The ISME Journal.

In The Last Decade

Yao Lu

43 papers receiving 370 citations

Hit Papers

Gut commensal Alistipes shahii improves experimental coli... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut commensal Alistipes shahii improves experimental colitis in mice with reduced intestinal epithelial damage and cytokine secretion
    2025 16 citations Mingchao Xu, Ruiting Lan et al. mSystems profile →

Peers

Yao Lu
Dianhui Tan China
Mobin Wan China
Kimberly L. Garrison United States
Shanming Wu China
Waleed Al–Hamoudi Saudi Arabia
Corinne Njapoum France
Toby Delahooke United Kingdom
Yu Asano Japan
Huanwei Zheng China
Dianhui Tan China
Yao Lu
Citations per year, relative to Yao Lu Yao Lu (= 1×) peers Dianhui Tan

Countries citing papers authored by Yao Lu

Since Specialization
Citations

This map shows the geographic impact of Yao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Lu more than expected).

Fields of papers citing papers by Yao Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Lu. The network helps show where Yao Lu may publish in the future.

Co-authorship network of co-authors of Yao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yao Lu. A scholar is included among the top collaborators of Yao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao Lu. Yao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Mingchao, Ruiting Lan, Dalong Hu, et al.. (2025). Gut commensal Alistipes shahii improves experimental colitis in mice with reduced intestinal epithelial damage and cytokine secretion. mSystems. 10(3). e0160724–e0160724. 16 indexed citations breakdown →
2.
Zhang, Shuwei, Yao Lu, Mingchao Xu, et al.. (2025). Alistipes putredinis Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats via Gut Microbiota Remodeling and Inflammatory Suppression. Nutrients. 17(12). 2013–2013. 3 indexed citations
3.
Ge, Yang, Yao Lu, James D. Allen, et al.. (2024). Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responses. Vaccine. 42(21). 126149–126149. 1 indexed citations
4.
Wang, Xiaomei, Kun He, Hao Xie, et al.. (2024). 四川盆地深层天然氢气形成机制. SCIENTIA SINICA Terrae. 1 indexed citations
5.
6.
Li, Minghui, Fangfang Sun, Xiaoyue Bi, et al.. (2022). Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection. Hepatology International. 17(1). 42–51. 5 indexed citations
7.
Cao, Weihua, Lu Zhang, Xiaoyue Bi, et al.. (2022). Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment. Frontiers in Immunology. 13. 891424–891424. 5 indexed citations
8.
Cao, Weihua, Minghui Li, Lu Zhang, et al.. (2021). The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated‐Interferon versus Entecavir Therapy. BioMed Research International. 2021(1). 2178143–2178143. 8 indexed citations
9.
Li, Minghui, Yao Lu, Fangfang Sun, et al.. (2021). Transforming growth factor β as a possible independent factor in chronic hepatitis B. Archives of Virology. 166(7). 1853–1858. 4 indexed citations
10.
Li, Minghui, Lu Zhang, Yao Lu, et al.. (2020). Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a. Virologica Sinica. 36(2). 311–320. 13 indexed citations
11.
Liu, Ruyu, Yanhui Chen, Jiang Guo, et al.. (2020). The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients. BMC Infectious Diseases. 20(1). 590–590. 7 indexed citations
12.
Liu, Ruyu, Jiang Guo, Yao Lu, et al.. (2019). Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy. Clinical and Experimental Medicine. 19(3). 309–320. 14 indexed citations
13.
Cao, Weihua, Minghui Li, Calvin Q. Pan, et al.. (2018). Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy. Journal of Interferon & Cytokine Research. 38(5). 197–205. 13 indexed citations
14.
Li, Minghui, Yao Lu, Lu Zhang, et al.. (2018). Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B. Chinese Medical Journal. 131(15). 1813–1818. 12 indexed citations
15.
Li, Minghui, Lu Zhang, Dan Zhang, et al.. (2018). Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection. Chinese Medical Journal. 131(1). 43–49. 11 indexed citations
16.
Li, Minghui, Dan Zhang, Lu Zhang, et al.. (2017). Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B. Chinese Medical Journal. 130(15). 1810–1815. 11 indexed citations
17.
18.
Li, Minghui, Lu Zhang, Yao Lu, et al.. (2017). Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment. Chinese Medical Journal. 130(5). 559–565. 17 indexed citations
19.
Li, Minghui, Lu Zhang, Yao Lu, et al.. (2016). Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a. World Journal of Hepatology. 8(15). 637–637. 23 indexed citations
20.
Li, Minghui, Yao Xie, Yao Lu, et al.. (2011). [High rates of HBsAg loss and seroconversion result from prolonged course of pegasys treatment].. PubMed. 19(3). 182–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dianhui Tan Breakdown of academic impact, for papers by Mobin Wan Breakdown of academic impact, for papers by Kimberly L. Garrison Breakdown of academic impact, for papers by Shanming Wu Breakdown of academic impact, for papers by Waleed Al–Hamoudi Breakdown of academic impact, for papers by Corinne Njapoum Breakdown of academic impact, for papers by Toby Delahooke Breakdown of academic impact, for papers by Yu Asano Breakdown of academic impact, for papers by Huanwei Zheng
Rankless by CCL
2026